Simcere proposes share mandates, dividend and director re-election

Simcere Pharmaceutical Group Limited (HKEX: 2096) announced plans for its upcoming AGM, where shareholders will vote on key resolutions including the proposed granting of general mandates to issue and repurchase shares. The company seeks approval to issue shares not exceeding 20% of its issued share capital as of the resolution date and to repurchase up to 10% of issued shares. As of the latest practicable date, Simcere had 2,486,320,618 shares in issue. The board also recommended a final dividend of RMB0.16 per share for the year ended December 31, 2024. Also to be voted on is the re-election of directors Ms. WANG Xi, Mr. WANG Xinhua and Mr. SUNG Ka Woon. The AGM is scheduled for June 13, 2025, in Shanghai, and shareholders are encouraged to vote by proxy if they cannot attend in person. The register of members will be closed during certain periods in June to determine eligibility for attending the AGM and receiving the final dividend.